The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
Therapy recently approved in Canada under the brand name KORSUVA
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
The medical team led by Dr. Babu Ezhumalai implanted the dual-chamber leadless pacemaker through a non-surgical procedure successfully
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Subscribe To Our Newsletter & Stay Updated
